Abstract
Human arylamine N-acetyltransferase type 1 (NAT1) has been cloned from human genomic DNA, into the vector pET(5a) and expressed in Escherichia coli. The recombinant protein has been purified to apparent homogeneity using anion exchange chromatography. The arylamine acceptor specificity, and the effect of potential NAT1 inhibitors has been investigated using purified recombinant protein. The K m of the recombinant NAT1 protein for the substrates para-aminobenzoate ( p-aba) and 4-aminosalicylate are 14.3 and 11.8 μM, respectively. Folate and amethopterin were found to be potent competitive inhibitors of p-aba acetylation, with K i values of 13.3 and 9.5 μM, respectively. The pteroate moiety of folate, in contrast is a poor inhibitor, with 100 μM pteroate inhibiting only 40% of NAT1 activity. A catabolite of folate para-aminobenzoly- l-glutamate has also been shown to be a NAT1 substrate with a K m value of 263 μM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
